kw.\*:("Nanomedicine")
Results 1 to 25 of 678
Selection :
Personalized NanomedicineLAMMERS, Twan; RIZZO, Larissa Y; STORM, Gert et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4889-4894, issn 1078-0432, 6 p.Article
A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studiesMUZAMIL YAQUB WANT; ISLAMUDDIN, Mohammad; CHOUHAN, Garima et al.Journal of colloid and interface science. 2014, Num 432, pp 258-269, issn 0021-9797, 12 p.Article
Nanomedicines for overcoming biological barriers : Drug delivery and drug efficacyALONSO, Maria José.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 3, pp 168-172, issn 0753-3322, 5 p.Article
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicinesEHMANN, Falk; SAKAI-KATO, Kumiko; ROBERT, Jean-Louis et al.Nanomedicine (London. Print). 2013, Vol 8, Num 5, pp 849-856, issn 1743-5889, 8 p.Article
Solubilization of Therapeutic Agents in Micellar NanomedicinesVUKOVIC, Lela; MADRIAGA, Antonett; KUZMIS, Antonina et al.Langmuir. 2013, Vol 29, Num 51, pp 15747-15754, issn 0743-7463, 8 p.Article
Oltre il visibile Le nanotecnologie e la nanomedicina : definizioni e problematiche bioetiche = Beyond the visible. Nanotechnologies and nanomedicine : definitions and bioethical issues = Au delà du visible. Les nanotechnologies et la nanomédecine : définitions et problèmes bioéthiquesSPAGNOLO, Antonio G; DALOISO, Viviana.Medicina e morale. 2008, Vol 58, Num 3, pp 527-553, issn 0025-7834, 27 p.Article
Toxicity of inorganic nanomaterials in biomedical imagingJINXIA LI; XUELING CHANG; XIAOXIA CHEN et al.Biotechnology advances. 2014, Vol 32, Num 4, pp 727-743, issn 0734-9750, 17 p.Conference Paper
Techniques for physicochemical characterization of nanomaterialsLIN, Ping-Chang; LIN, Stephen; WANG, Paul C et al.Biotechnology advances. 2014, Vol 32, Num 4, pp 711-726, issn 0734-9750, 16 p.Conference Paper
Synthetic immunosurveillance systems: Nanodevices to monitor physiological eventsWOAPPI, Yvon L; JANGITI, Rahul; SINGH, Om V et al.Biosensors & bioelectronics. 2014, Vol 61, pp 152-164, issn 0956-5663, 13 p.Article
Improving the translation in Europe of nanomedicines (a.k.a. drug delivery) from academia to industryEATON, Michael A. W.Journal of controlled release. 2012, Vol 164, Num 3, pp 370-371, issn 0168-3659, 2 p.Article
Raman spectroscopy in nanomedicine: current status and future perspectiveKEATING, Mark E; BYRNE, Hugh J.Nanomedicine (London. Print). 2013, Vol 8, Num 8, pp 1335-1351, issn 1743-5889, 17 p.Article
Exosomes as Immunotheranostic Nanoparticles : EXTRACELLULAR EXOSOMES AND MICROVESICLES IN ALLERGIC AND IMMUNOLOGICAL DISEASESNATASHA, G; GUNDOGAN, Buket; AARON TAN et al.Clinical therapeutics. 2014, Vol 36, Num 6, pp 820-829, issn 0149-2918, 10 p.Article
Nanodelivery Systems for Improved Topical Antimicrobial TherapyBASNET, Purusotam; SKALKO-BASNET, Nataša.Current pharmaceutical design (Print). 2013, Vol 19, Num 41, pp 7237-7243, issn 1381-6128, 7 p.Article
Advanced Nanobiomaterials for Tissue Engineering & Regenerative MedicineCHEE KAI CHUA; LAY POH TAN; JIA AN et al.Nanomedicine (London. Print). 2013, Vol 8, Num 4, issn 1743-5889, 168 p.Serial Issue
Innovation in Nanomedicine through Materials NanoarchitectonicsKUJAWA, Piotr; WINNIK, Françoise M.Langmuir. 2013, Vol 29, Num 24, pp 7354-7361, issn 0743-7463, 8 p.Article
Pharmacytes : An ideal vehicle for targeted drug deliveryFREITAS, Robert A.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 2769-2775, issn 1533-4880, 7 p.Article
Why healthcare open innovation is failing for nanomedicinesEATON, Michael A. W.European journal of nanomedicine (Print). 2013, Vol 5, Num 4, pp 213-215, issn 1662-5986, 3 p.Article
Les nanomédicaments : Nanomédecine: Du labo au marchéFATTAL, Elias; BOCHOT, Amélie; HILLAIREAU, Hervé et al.Biofutur (Puteaux). 2012, Num 333, pp 26-29, issn 0294-3506, 4 p.Article
First cross border conference on nanosciences and materials for health. Nano SMH (21-25 june 2010, Pont-à-Mousson)Cross border conference on nanosciences and materials for health. 2010, 1Vol, 64 p.Conference Proceedings
NEUROSURGERY IN THE REALM OF 10-9, PART 1: STARDUST AND NANOTECHNOLOGY IN NEUROSCIENCE. CommentaryELDER, James B; LIU, Charles Y; APUZZO, Michael L. J et al.Neurosurgery. 2008, Vol 62, Num 1, pp 1-20, issn 0148-396X, 20 p.Article
NEUROSURGERY IN THE REALM OF 10-9, PART 2: APPLICATIONS OF NANOTECHNOLOGYTO NEUROSURGERY-PRESENT AND FUTURE. CommentariesELDER, James B; LIU, Charles Y; APUZZO, Michael L. J et al.Neurosurgery. 2008, Vol 62, Num 2, pp 269-285, issn 0148-396X, 17 p.Article
Chemoradiotherapy of Human Tumors: Novel Approaches from NanomedicineWERNER, Michael Edward; FOOTE, Michael Bonner; WANG, Andrew Zhuang et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 19, pp 2830-2837, issn 1381-6128, 8 p.Article
Nanotheranostics for personalized medicineMURA, Simona; COUVREUR, Patrick.Advanced drug delivery reviews. 2012, Vol 64, Num 13, pp 1394-1416, issn 0169-409X, 23 p.Article
Surface functionalized biocompatible magnetic nanospheres for cancer hyperthermiaXIANQIAO LIU; NOVOSAD, Valentyn; ROZHKOVA, Elena A et al.IEEE transactions on magnetics. 2007, Vol 43, Num 6, pp 2462-2464, issn 0018-9464, 3 p.Conference Paper
Epigenetics advancing personalized nanomedicine in cancer therapySHUJUN LIU.Advanced drug delivery reviews. 2012, Vol 64, Num 13, pp 1532-1543, issn 0169-409X, 12 p.Article